Concepedia

Mark Hopley

MH

Statistics

Publications

19

Citations

1.1K

H-Index

15

Active since

1998

Affiliations

University of the Witwatersrand(Current)

Chris Hani Baragwanath Hospital

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (United States)

Johns Hopkins Medicine

Mark Hopley is an author at University of the Witwatersrand specializing in medicine, life sciences, and chronic kidney disease.

Publications per year

1998–2023

19

Publications

19

The Addition of Pentoxifylline to Conventional Therapy Improves Outcome in Patients with Peripartum Cardiomyopathy

Karen Sliwa, Daniel Skudicky, Geoffrey Candy et al. · European Journal of Heart Failure · 2002 · 186 citations · Full text

, , +5

Causes and predictors of death in South Africans with systemic lupus erythematosus

S Wadee, Mohammed Tikly, Mark Hopley · Lara D. Veeken · 2007 · 136 citations · Full text

, , +15

Percutaneous Embolotherapy for Life-Threatening Hemoptysis

Michelle Wong, Peter Szkup, Mark Hopley · CHEST Journal · 2002 · 124 citations

, , +7

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial

William G. Herrington, Christoph Wanner, Parminder K. Judge et al. · Nephrology Dialysis Transplantation · 2022 · 108 citations · Full text

, , +17

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

, , +11

1–5 of 19